TF and COVID-19: COVID-19 can lead to a form of disseminated intravascular coagulation (DIC) and many of the critically ill COVID-19 patients with poor prognosis are in a systemic procoagulant state (Arachchillage and Laffan, 2020; Connors and Levy, 2020; Klok et al., 2020; Magro et al., 2020; Oxley et al., 2020; Spyropoulos et al., 2020; Tang et al., 2020; Wang T. et al., 2020; Zhang et al., 2020; Zhou et al., 2020), and MSC products are known to express variable levels of a highly procoagulant tissue factor (TF/CD142) (Morrissey, 2004).